- Full text PDF available (1)
Recombinant human PH20 hyaluronidase (rHuPH20) is used to facilitate dispersion of subcutaneously delivered fluids and drugs. This report summarizes rHuPH20 immunogenicity findings from clinical trials where rHuPH20 was co-administered with SC human immunoglobulin, trastuzumab, rituximab, or insulin. Plasma samples were obtained from evaluable subjects… (More)
Errors by the authors were inadvertently published in Table I and the supplemental material. The correct Table I is below and the corrected supplemental material can be found by accessing the original article.